(lp0
S'Vericel Corp.: Promising Biotech Looking To Pioneer In Tissue Regeneration Seeking Alpha - Dec 7, 2016 I am using this opportunity to present a unique short-term investment opportunity leading into catalyst events for Vericel Corp . From a technical perspective, the charts for Vericel Corporation, a commercial-stage biopharmaceutical ...'
p1
aS'Vericel Corp. VCEL  Wall Street Journal - Nov 27, 2014 News Vericel Corp.VCEL. Significant News Only. 04/10/17; Press Release. Vericel Announces Appointment of Michael Halpin as Senior Vice President, Quality and Regulatory Affairs.'
p2
aS'Vericel Corporation Announces Proposed Public Offering of Common Stock GlobeNewswire  - Dec 15, 2016 CAMBRIDGE, Mass., Dec. 15, 2016  -- Vericel Corporation , a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that it intends&nbsp;...'
p3
aS'2.60 MarketWatch - Nov 28, 2014 Vericel Corp. Vericel Corp. engages in the development of patient-specific expanded cellular therapies for use in the treatment of patients with severe diseases and conditions.'
p4
aS"Vericel Corporation's  CEO Nick Colangelo on Q3 2016 Results - Earnings ... Seeking Alpha - Nov 8, 2016 With us on today's call are Nick Colangelo, Vericel's President and Chief Executive Officer; Dan Orlando, Vericel's Chief Operating Officer; Dr. David Recker, our Chief Medical Officer and Dr. Ross Tubo, Vericel's Chief Scientific Officer. I will now ..."
p5
aS"Vericel Announces First MACI Implant in the United States for the Treatment of ... GlobeNewswire  - Feb 1, 2017 CAMBRIDGE, Mass., Feb. 01, 2017  -- Vericel Corporation , a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced the first implant&nbsp;...BRIEF-Vericel announces first MACI implant in USto treat symptomatic cartilage ... - ReutersFirst US patient treated with Vericel's MACI; shares ahead 15% premarket - Seeking Alpha"
p6
aS"Form 8-K Vericel Corp For: Mar 10 StreetInsider.com - Mar 10, 2017 CAMBRIDGE, Mass., March 10, 2017  - Vericel Corporation , a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today reported financial results&nbsp;...Vericel's  CEO Nick Colangelo on Q4 2016 Results - Earnings Call Transcript - Seeking Alpha"
p7
aS"Vericel Corporation Announces Exercise of Underwriters' Over-Allotment Option ... GlobeNewswire  - Dec 21, 2016 CAMBRIDGE, Mass., Dec. 21, 2016  -- Vericel Corporation , a leading developer of expanded autologous cell therapies for the treatment of patients with serious diseases and conditions, today announced that it has&nbsp;...FDA OKs Maci Implant for Repair of Cartilage Defects in the Knee - Physical Therapy Products"
p8
aS'Analysts Anticipate Vericel Corp  to Post -$0.19 Earnings Per Share BBNS - 15 hours ago Vericel Corp logo Analysts forecast that Vericel Corp  will post earnings per share  of  for the current quarter, Zacks reports.Vericel  Reaches $2.57 After 5.00% Down Move; Shorts at Calpine (CPN ... - Key Gazette'
p9
aS'Technical Levels in Focus for Vericel Corp  Rives Journal - 17 hours ago Tracking moving averages is one of the most universally used techniques for performing technical stock analysis. Checking on some levels for Vericel Corp , the 50-day Moving Average is currently 2.81, the 200-day Moving Average is 2.57, and the&nbsp;...'
p10
a.